![]() | |
Clinical data | |
---|---|
Other names | UR-AK49 |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C16H27N5O |
Molar mass | 305.426 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
UR-AK49 is a drug used in scientific research which acts as a potentantagonist for theNeuropeptide Y /Pancreatic polypeptidereceptorY4, and also as apartial agonist at thehistamine receptorsH1 andH2.[1] UR-AK49 is a pure antagonist at Y4 with no partial agonist effects, and although it is only slightly selective for Y4 over the relatedY1 andY5 receptors, as the first non-peptide Y4 antagonist developed UR-AK49 is expected to be useful in the study of this receptor and its role in the body.[2]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |